Management and key personnel invest SEK 19.2 million in Brighter through a directed share issue

Management and key personnel in Brighter AB (publ) invest SEK 19.2 million in Brighter through a directed share issue, which was resolved by the Extraordinary General Meeting on November 11, 2019. A total of 2,629,430 shares were subscribed at a subscription price of SEK 7.30. The offer was thus fully subscribed.

The payment for subscribed shares is paid in cash. The subscription price corresponds to the recalculated strike price according to the terms of the warrants in Program 2016/19 Series I and Program 2016/19 Series II.

The number of shares increases by 2,629,430 shares, from 93,397,483 to 96,026,913 shares. The share capital increases by SEK 131,471.50, from SEK 4,669,874.15 to SEK 4,801,345.65.

Background

The warrants in Program 2016/19 Series I (then Board members) and Program 2016/19 Series II (then staff and key persons), resolved on the AGM 17 May 2016, were inadvertently never registered with the Swedish Companies Registration Office. In order to compensate those who would have held the warrants for their absent opportunity to subscribe for shares in the Company, these persons were given the right to subscribe for shares within the framework of a directed share issue.

About Brighter AB (publ)

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

For further information, please contact:

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
Email: ann.zetterberg@brighter.se

Henrik Norström, CEO  
Phone: +46 733 40 30 45     
Email: henrik.norstrom@brighter.se

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 13:58 CET on November 22, 2019.

About Us

Brighter is a Swedish health-tech company with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se

Subscribe

Documents & Links